Section 32
About
Section 32 is a venture capital fund investing at the frontiers of technology and healthcare. Founded by Bill Maris, the team has vast experience building iconic companies. Our goal is to improve the human condition by accelerating the discovery, development and distribution of important technologies and life saving medicines.
Key facts
At-a-glance profile data
- Website
- s32.com
- Type
- Venture Capital
- Headquarters
- San Diego, California
- Funds raised
- $1.5B
- Portfolio companies
- 3
- Stages
- SeedSeries ASeries B
- Cheque size
- $4M to $110M
- Sector focus
- HealthcareGenomicsCancerTumor DetectionDNA
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 4 Sept 2025 | Sola Security | Series A1 | $5M |
| 22 Jul 2025 | Reka AI | Series B | $110M |
| 27 Apr 2025 | TollBit | Series A | $24M |
| 11 Mar 2025 | Sola Security | Series A | $30M |
| 8 Jul 2024 | Sola Security | Seed | $30M |
| 23 May 2024 | Elysian | Undisclosed round | $31M |
| 22 Mar 2022 | Nucleai | Series B | $33M |
| 18 Apr 2021 | C2i Genomics | Series B | $100M |
Add first review
Frequently asked
What companies has Section 32 invested in?
Section 32 has invested in Sola Security, Reka AI, TollBit, Elysian, Nucleai and 1 more.
Founders (1)